IPO registrations (S-1, F-1) · Registrants
SALIX PHARMACEUTICALS LTD
- SEC CIK
- 1009356 · filings on EDGAR ↗
- Name on the registration
- SALIX HOLDINGS LTD
- Former names
- SALIX HOLDINGS LTD (1997–1998)
- Registration
- Form S-1, first filed 1997-08-15, last 1997-10-14; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 1997-10-17
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 8510 COLONNADE CENTER DRIVE, Raleigh, NC 27615
- EIN
- 94-3267443
- EDGAR entity type
- operating
- Insiders and CEO pay
- SALIX PHARMACEUTICALS LTD on the corporate pages
Offering terms
- Final price
- $3.72 per share (424B4 filed 1997-10-17, an initial public offering)
- Shares sold
- 3,000,000
- Gross proceeds
- $11,160,000 before underwriting discounts and any over-allotment option
- Listing
- TSX under the symbol SLX.s
- Lead underwriters
- Levesque Beaubien Geoffrion Inc (900,000 shares); Yorkton Securities Inc (900,000 shares); Marleau, Lemire Securities Inc (600,000 shares); Midland Walwyn Capital Inc (600,000 shares)
- Syndicate
- Nbc Levesque International Ltd. Yorkton Capital Inc; Marleau, Lemire Securities Inc. Midland Walwyn Capital Corporation
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Federal award recipient: SALIX PHARMACEUTICALS, INC. Fuzzy (name and state)
- Form D issuer: SALIX PHARMACEUTICALS LTD EXACT (CIK (EXACT))
- SEC filer: SALIX PHARMACEUTICALS LTD EXACT (CIK (EXACT))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
Filings 4
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 1997-08-15 | S-1 | S-1 (registration) | SALIX HOLDINGS LTD | 0001012870-97-001598 ↗ |
| 1997-09-25 | S-1/A | S-1/A (amendment) | SALIX HOLDINGS LTD | 0001012870-97-001862 ↗ |
| 1997-10-14 | S-1/A | S-1/A (amendment) | SALIX HOLDINGS LTD | 0000898430-97-004281 ↗ |
| 1997-10-17 | 424B4 | 424B4 (final prospectus) | SALIX HOLDINGS LTD | 0001012870-97-001994 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 1997-10-14 | S-1/A | registration statement | $3.72 | 3,000,000 | $11,160,000 | TSX SLX.s | 2 | from the submission text; price line, shares headline, proceeds computed, cover names 2 | document ↗ | |
| 1997-10-17 | 424B4 | final prospectus | $3.72 | 3,000,000 | $11,160,000 | TSX SLX.s | 6 | from the submission text; price line, shares headline, proceeds computed, underwriting table 4, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| HARRAL WILLIAM III | Director | 8 | 2006–2008 | ||
| KEANE WILLIAM P | Director | 25 | 2006–2015 | ||
| LOGAN CAROLYN J | Director,Officer | President & CEO | 41 | 2006–2014 | |
| D ALONZO THOMAS | Director; Director,Officer | Acting Chief Executive Officer; Acting President and CEO | 30 | 2006–2015 | |
| CHAPPELL JOHN F | Director; Director,Officer | Chairman of the Board | 52 | 2006–2015 | |
| DERBYSHIRE ADAM C | Officer | EVP Finance/CFO; Sr. VP Finance/CFO | 71 | 2006–2014 | |
| Forbes William P | Officer | EVP Research&Devel & CDO; President, Medical R&D and CDO; President, Medical, R&D & CDO; V.P. Research& Devel & CDO | 38 | 2006–2015 | |
| FRANCO RICHARD A | Director | 23 | 2006–2012 | ||
| Taylor David N MD | Officer | VP - Chief Medical Officer | 1 | 2006 | |
| Reeth Mark D | Officer | Gen Counsel&VP Corp Compliance | 17 | 2007–2012 | |
| Sirgo Mark A | Director | 26 | 2008–2015 | ||
| DEERFIELD CAPITAL LP | TenPercentOwner; TenPercentOwnerOther | 9 | 2008–2009 | ||
| DEERFIELD INTERNATIONAL LTD | TenPercentOwner; TenPercentOwnerOther | 10 | 2008–2009 | ||
| DEERFIELD MANAGEMENT CO /NY | TenPercentOwner; TenPercentOwnerOther | 10 | 2008–2009 | ||
| DEERFIELD PARTNERS, LP | TenPercentOwner; TenPercentOwnerOther | 9 | 2008–2009 | ||
| Flynn James E | TenPercentOwner; TenPercentOwnerOther | 10 | 2008–2009 | person page Fuzzy | |
| Scruggs Rick D | Officer | Executive Vice President | 20 | 2011–2015 | |
| Bertrand William C JR | Officer | Gen Counsel&VP Corp Compliance; See Remarks | 5 | 2013–2015 | |
| CREECH TIMOTHY J | Officer | See Remarks | 4 | 2014–2015 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2014-01-10 | SALIX PHARMACEUTICALS LTD | Pharmaceuticals | $750,000,000 | $750,000,000 | 7 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Plan sponsor | SALIX PHARMACEUTICALS, INC. | NC | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | SALIX PHARMACEUTICALS, INC. | NC | Federal spending (USAspending) | name and state |
| Form D issuer | SALIX PHARMACEUTICALS LTD | NC | Form D private offerings | CIK (EXACT) |
| SEC filer | SALIX PHARMACEUTICALS LTD | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Salix Pharmaceuticals, Ltd. | NC | Trademarks (USPTO) | name and state |
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, NC first:
- TRIANGLE PHARMACEUTICALS INC NC
- INSPIRE PHARMACEUTICALS INC NC
- POZEN INC /NC NC
- ARGOS THERAPEUTICS INC NC
- CHIMERIX INC NC
- ENDEAVOR PHARMACEUTICALS INC NC
- CORNERSTONE THERAPEUTICS INC NC
- Talecris Biotherapeutics Holdings Corp. NC
- Biolex Therapeutics, Inc. NC
- CURAXIS PHARMACEUTICAL Corp NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health